KH903

· Chengdu Kanghong Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KH903, covering 2020-09-18 to 2020-09-18. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy [Phase 2]

See pricing